• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.8405 -0.0003 (-0.04%)
Official Closing Price Updated: 8:00 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,021
Open 0.8431
Bid (Size) 0.8200 (900)
Ask (Size) 0.8594 (3,000)
Prev. Close 0.8408
Today's Range 0.8009 - 0.8431
52wk Range 0.7350 - 18.90
Shares Outstanding 4,168,223
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Participates in SCOPE Summit 2026 Ahead of Phase 2a Concussion Trial
Today 9:45 EST
Via Investor Brand Network
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Present at Sequire Investor Summit 2026
January 14, 2026
Via Investor Brand Network

Performance

YTD
+0.7%
+0.7%
1 Month
-3.8%
-3.8%
3 Month
-31.1%
-31.1%
6 Month
-33.3%
-33.3%
1 Year
-90.4%
-90.4%

More News

Read More
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Advances Toward First Clinical Trial and Expands AI-Driven Neurology Pipeline
November 12, 2025
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Oragenics Q3 2025 Shareholder Update
November 12, 2025
From Oragenics, Inc.
Via Business Wire
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Regains NYSE Compliance, Strengthens Balance Sheet for Clinical Advancement
October 21, 2025
Via Investor Brand Network
News headline image
Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
October 21, 2025
From Oragenics, Inc.
Via Business Wire
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Partners with Receptor.AI to Accelerate AI-Driven Discovery of Brain-Targeted Therapeutics
October 07, 2025
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development
October 07, 2025
From Oragenics
Via Business Wire
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Highlights Q2 2025 Progress and Prepares for Phase IIa Concussion Trial
August 11, 2025
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Selects Southern Star Research as CRO for Phase IIa Trial of Intranasal Concussion Therapy ONP-002
July 31, 2025
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Secures U.S. Manufacturing Partner Ahead of Phase IIb Trials for Concussion Drug
July 16, 2025
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
July 07, 2025
Via Benzinga
News headline image
Monday's after hours session: top gainers and losers ↗
July 07, 2025
Via Chartmill
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Secures $16.5 Million in Preferred Stock Offering to Advance Intranasal Concussion Therapy
July 03, 2025
Via Investor Brand Network
News headline image
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
July 02, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
July 01, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
July 01, 2025
Via Chartmill
News headline image
Which stocks are moving on Tuesday? ↗
July 01, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
July 01, 2025
Via Benzinga
News headline image
Nasdaq Dips 150 Points; US ISM Manufacturing PMI Rises In June ↗
July 01, 2025
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
July 01, 2025
Via Chartmill
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
July 01, 2025
Via Chartmill
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Announces $20 Million Preferred Stock and Warrant Offering
July 01, 2025
Via Investor Brand Network
News headline image
US Stocks Mixed; Dow Gains Over 50 Points ↗
July 01, 2025
Via Benzinga
Topics Stocks
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
July 01, 2025
Via Chartmill

Frequently Asked Questions

Is Oragenics Inc. Common Stock publicly traded?
Yes, Oragenics Inc. Common Stock is publicly traded.
What exchange does Oragenics Inc. Common Stock trade on?
Oragenics Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Oragenics Inc. Common Stock?
The ticker symbol for Oragenics Inc. Common Stock is OGEN on the New York Stock Exchange
What is the current price of Oragenics Inc. Common Stock?
The current price of Oragenics Inc. Common Stock is 0.8405
When was Oragenics Inc. Common Stock last traded?
The last trade of Oragenics Inc. Common Stock was at 02/02/26 08:00 PM ET
What is the market capitalization of Oragenics Inc. Common Stock?
The market capitalization of Oragenics Inc. Common Stock is 3.50M
How many shares of Oragenics Inc. Common Stock are outstanding?
Oragenics Inc. Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap